Otsuka (OTCMKTS:OTSKY) Upgraded at Zacks Research

Zacks Research upgraded shares of Otsuka (OTCMKTS:OTSKY) from a strong sell rating to a hold rating in a research report report published on Monday morning,Zacks.com reports.

Otsuka Price Performance

Shares of Otsuka stock opened at $26.54 on Monday. The business has a 50-day moving average of $27.27 and a 200-day moving average of $25.17. The company has a market capitalization of $28.51 billion and a PE ratio of 0.18. Otsuka has a 1-year low of $21.64 and a 1-year high of $32.41.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.